Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Roivant Sciences Ltd.SHS(ROIV) | 12,228,465 | 12,228,465 | 0 | $129.25M | $141.12M | 52.38% | +$11.86M |
| Liquidia Corporation(LQDA) | 7,182,532 | 7,182,532 | 0 | $86.19M | $71.83M | 26.66% | -$14.37M |
| Cullinan Therapeutics, Inc.(CGEM) | 0 | 824,705 | +824,705 | $0 | $13.81M | 5.12% | +$13.81M |
| Insmed Incorporated(INSM) | 0 | 171,704 | +171,704 | $0 | $12.53M | 4.65% | +$12.53M |
| EyePoint, Inc.(EYPT) | 0 | 1,361,979 | +1,361,979 | $0 | $10.88M | 4.04% | +$10.88M |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 325,789 | +325,789 | $0 | $7.32M | 2.72% | +$7.32M |
| Pharvaris N.V. COM | 0 | 242,341 | +242,341 | $0 | $4.49M | 1.67% | +$4.49M |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 128,569 | +128,569 | $0 | $2.64M | 0.98% | +$2.64M |
| Enliven Therapeutics, Inc. | 0 | 90,572 | +90,572 | $0 | $2.31M | 0.86% | +$2.31M |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 235,498 | +235,498 | $0 | $2.05M | 0.76% | +$2.05M |
| Astria Therapeutics, Inc. | 0 | 39,422 | +39,422 | $0 | $434.0K | 0.16% | +$434.0K |